San Francisco, California

Intercontinental San Francisco

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers.  We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS San Francisco

Hilton Waikoloa Village | Waikoloa, Hawaii

PRIMO is a unique opportunity to receive CME/CE credits while staying ahead of the latest advances in immuno and molecular oncology. The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.

This activity has been designed to meet the educational needs of Academic and Community Practitioners, as well as Registered Nurses and Advances Practice Registered Nurses, Pharmacists and Physician Assistants from all oncology specialties, treating all disease sites involved in the care of patients with cancer.

For complete conference details, hotel and registration information please visit: PRIMO 2022

Las Vegas, Nevada

This master lecture series will provide the most up-to-date, practical information on the management of breast cancer, lung cancer, gastrointestinal, genitourinary and melanoma in 2021. Immunotherapy and target therapies will be discussed in personalized treatments, and the latest clinical data impacting the management of these cancers.  We will discuss the most current data in GI, GU (PARP Inhibitors), Melanoma (Immunotherapy/BRAF), Lung (RET/MET/VEGFR2) and breast cancer (HER2 P13K/Akt/TROP2).

Cutting edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

For complete conference details, hotel and registration information please visit MLS Las Vegas

San Juan, Puerto Rico

La Concha Renaissance Resort

The progress made in genomics, proteomic, oncogenic pathways and ultimately, development of new therapeutic targets continues moving quickly that there are so many paradigms shifts in cancer care that there is an on demand for up-to-date information.

This interprofessional activity is designed for physicians, advanced practice registered nurses, oncology nurses, physician assistants, pharmacists, and professionals in training from these disciplines to build a stronger collaborative partnership with other members of the cancer care team as well as oncology specialists.

This symposium strives to bridge the gap in patient outcomes, promoting and encouraging the forward synergy of this educational activity, bringing to the forefront novel therapies in oncology.  Each session concludes with a round table and panel discussion maximizing faculty and attendee interaction.

For complete conference details, hotel and registration information please visit WCS 2022

Miami, Florida

JW Marriott Miami

Presentations from the latest national (AACR, ASCO, SABC, and ASH) and international forums (ESMO and WCLC) meetings will be discussed and guidelines of cancer care using a team approach will be emphasized. The participants in the conference will have the opportunity not only to learn, review, and understand the state-of-the-art management in cancer care using a team approach but also engage in personal interaction with our panel of experts in these subjects during the question-and-answer sessions.

Topics in solid tumors and hematological malignancies will be reviewed and will include topics in breast cancer, lung cancer, gastrointestinal (GI) malignancies, gynecologic malignancies, genitourinary (GU) cancers, head and neck cancers, melanoma, and hematological malignancies such as multiple myeloma, CLL and non-Hodgkin’s lymphoma. There will also be a special session devoted to the area of palliative care, survivorship in oncology, targeted therapy and immunotherapy side effects management.

The areas of focus for this conference will include the current standards of care in the treatment of all mentioned malignancies and new developments in these areas of cancer care. There will be much emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. There will be reviews of new chemotherapeutic, antiangiogenic, and immunotherapeutic agents.

For complete conference details, hotel and registration information please visit MCM 2022